|
(ÁÖ)Áö¿¡½º½ºÅÄ´Ùµå |
CRA, PMä¿ë
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
02.12 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Post Marketing Surveillance lead
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
5³â¡è |
ä¿ë½Ã |
04.27 |
|
|
(ÁÖ)ÄÚ¸®¾ÆÈÞ¸Õ¸®¼Ò½Ã½º |
µ¶¼º ¾à¸®ºÐ¾ß 5³â ÀÌ»ó
´ëÀü ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
09.19 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Clinical Project Leader
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
08.10 |
|
|
(ÁÖ)µå¸²º¸¿ì |
äÇ÷ Ç÷´ç±â¼¾¼ ȸ»ç °æ·ÂÁ÷ ¸ðÁý(¹Ú»ç±Þ,ÈÇÐ ÈÇаøÇÐÀü
´ë±¸ µ¿±¸ | ´ëÇпø(¹Ú»ç) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
11.15 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Clinical Project Leader
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.05 |
|
|
Çѱ¹½ºÆ®¶óÀÌÄ¿(ÁÖ) |
Business Development Manager
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
5³â¡è |
ä¿ë½Ã |
01.12 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA I/II (Lead Monitor Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.01 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Clinical Project Leader
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.02 |
|
|
´º¸ÞÀ̽º |
[Ã¥ÀÓ±Þ] ¹ÙÀÌ¿À ÀǾàÇ° ¿¬±¸ °³¹ß GMP °øÁ¤°ü¸® ¿¬±¸¿ø
¼¿ï ¼´ë¹®±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
06.01 |
|
|
Å©¸®½ºÅ»Áö³ë¹Í½º(ÁÖ) |
³Ø½Ã¿À·¦ GLP ºÐ¼®½ÃÇèÃ¥ÀÓÀÚ °æ·ÂÁ÷ ä¿ë
¼¿ï ±Ýõ±¸ | Çз¹«°ü |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
01.29 |
|
|
¹ÙÀÌ¿À´Ï¾Æ |
ÀÚȸ»ç(½á³ªÁ¨Å׶óǻƽ½º) ¿Ã¸®°íÇÕ¼º Chemist ¸ðÁý
´ëÀü À¯¼º±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
12.15 |
|
|
ÁöÀÌÇコÄɾîÄÚ¸®¾Æ |
GE Healthcare Scientist ¹ÙÀÌ¿ÀÀǾàÇ° ºÐ¼®¾÷¹«
ÀÎõ ¿¬¼ö±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
01.30 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Clinical Project Leader
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.08 |
|
|
ÀÌ¿ÀÇ÷οì ÁÖ½Äȸ»ç |
[ÀÌ¿ÀÇ÷οì] CRA ä¿ë(°ú/Â÷Àå)
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.04 |
|